after levofloxacin use has not been evaluated. isolates recovered from stool cultures before and after levofloxacin prophylaxis in patients with neutropenia from August 2011 to May 2013. Some patients received chemotherapy multiple times., most of which were extended-spectrum β-lactamase (ESBL) producers, were already detected in approximately 20% of all patients before the initiation of prophylaxis. FN-related bacteremia developed in 2 patients, accompanied by a good prognosis. as a local factor may influence strategies toward the use of quinolone prophylaxis
Fluoroquinolones are the most attractive agents for prophylactic use in neutropenic cancer patients,...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Administration of antimicrobial agent is the most frequent and significant cause of modifications to...
Background: Fluoroquinolone prophylaxis in patients with neutropenia and hematological malignancies ...
Gram-positive breakthrough infections pose a major drawback to the use of quinolones for antibacteri...
The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial an...
Background: The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is cont...
SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
ABSTRACTBackgroundThe emergence of resistance has been demonstrated in cancer treatment centers wher...
AbstractFew studies have evaluated the role of antibacterial prophylaxis during neutropenia in patie...
Bacterial infections remain a major source of morbidity and mortality in neutropenic patients. There...
Objectives: Recent studies have shown a beneficial impact of fluoroquinolones on infection-related m...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
Severe infections duue to gram negative bacilli, staphylococci, enterococci and candida species are ...
Fluoroquinolones are the most attractive agents for prophylactic use in neutropenic cancer patients,...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Administration of antimicrobial agent is the most frequent and significant cause of modifications to...
Background: Fluoroquinolone prophylaxis in patients with neutropenia and hematological malignancies ...
Gram-positive breakthrough infections pose a major drawback to the use of quinolones for antibacteri...
The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is controversial an...
Background: The prophylactic use of fluoroquinolones in patients with cancer and neutropenia is cont...
SummaryBackgroundThe routine use of fluoroquinolone prophylaxis in patients with neutropenia and hem...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
ABSTRACTBackgroundThe emergence of resistance has been demonstrated in cancer treatment centers wher...
AbstractFew studies have evaluated the role of antibacterial prophylaxis during neutropenia in patie...
Bacterial infections remain a major source of morbidity and mortality in neutropenic patients. There...
Objectives: Recent studies have shown a beneficial impact of fluoroquinolones on infection-related m...
Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leu...
Severe infections duue to gram negative bacilli, staphylococci, enterococci and candida species are ...
Fluoroquinolones are the most attractive agents for prophylactic use in neutropenic cancer patients,...
Infectious complications are an important cause of morbidity and mortality in patients with hematolo...
Administration of antimicrobial agent is the most frequent and significant cause of modifications to...